Gout

In the midst of planning Thanksgiving dinner and watching the best NFL matchups, the last thing patients want to think about is an inconvenient gout flare-up. Unfortunately, it looks like November is prime-time for the debilitating condition.

The prevalence of gout in more affluent countries seems to be increasing in recent decades. Medications, co-morbidities, genetics and other risk factors are to blame.

The terminology used to describe gout in the medical literature is vague and sometimes confusing, new research finds.

Although gout has historically been thought to be a rare in patients with SLE, a recent case series suggests that the incidence of gout in SLE may be greater than previously thought, University of Michigan researchers report.

The indirect costs of gout can be as much as $18,362 per patient each year, research shows.

Chronic consumption of sugar-sweetened beverages leads to increased BMI and gout risk, study shows.

Ultrasound may be an excellent diagnosis tool for gout, if doctors can agree on what they are looking at.

Gout is on the rise globally. A Brazilian researcher who surveyed that nation's rheumatologists found some are ignoring--or unaware of--guidelines on how to treat the ailment.

Gout has been making quite a stir in news recently. Between a new classification system and a study showing that a common food can cause painful flares, this form of arthritis is getting quite a bit of attention. Now comes word that a drug used to treat gout could also be effective for another damaging condition.

Research shows a possible biological basis between gout, tomatoes and other foods.

Patients with tophaceous gout rarely develop ulcers, but when they do occur, these ulcers can be difficult to treat. This case study explores the diagnosis of and treatment options for patients with ulcerated tophaceous gout.

Two commonly prescribed gout therapies have also been shown to successfully treat another life-altering condition, researchers reported.

It may not be a surprise that having more gout flares in a year is more costly, but a recent study has quantified just how much more expensive they are.

Allopurinol's overall impact on the risk of mortality has been studied but is not yet well-understood. Now, a study has shown that the benefits from this treatment likely outweigh the risk of serious side effects.

Gout attacks really do occur more often at night, and here is proof. Theories abound as to why, but effective prophylactic treatments to reduce the risk of nocturnal exacerbations appear to be just what the doctor ordered.

Patients with gout may find relief from severe inflammatory pain due to recently explored peripheral system channels.

Erectile dysfunction (ED) may be a more common comorbidity than previously thought among patients with gout. Patients with gout may also be more likely to have severe ED.

Research shows febuxostat is more effective than allopurinol in reducing serum urate levels in patients with gout.

A recent interest in the effects of neutrophil extracellular traps in gout tophi could shed light on inflammatory processes in other autoimmune diseases.

In court decision to approve generic colchicine for gout, American College of Rheumatology arguments about the risk to patients of exorbitant pricing may have played an important role. Is this a harbinger of something?

(VIDEO) A gout drug with a new mechanism is showing promise in combination with existing remedies. In this interview, a leader in its progress to market tells why lesinurad could help put an undertreated disorder in a new light.

The 45-year-old woman turned up in the emergency room with an acutely painful, swollen thumb. Aspiration results were uninformative. What's the diagnosis?